According to Fu, C. et al., changes in DNA methylation, gene mutations, and modifications made to SERPINA1 after it is produced were all found to be strongly and positively associated with its expression levels in breast cancer, making it a potential diagnostic marker. Here, SERPINA1 is linked to breast carcinoma.